Email Alert RSS
Volume 10 Issue 1
Feb.  2020
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2019  >  10(1): 6-10
Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002
Citation: Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002
shu

New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine

doi: 10.3969/j.issn.1674-9081.2019.01.002
  • 1.

    Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Radiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 3.

    Center for Rare Diseases Research Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information
  • Corresponding author: ZHANG Shu-yang  TEL:010-69155068,E-mial:zhangshuyang2018@126.com
  • Received Date: 2018-10-04
  • Publish Date: 2020-02-01
    Abstract
  • Primary cardiomyopathies were previously defined as primary myocardial disorders of unknown causes, in which the secondary effect of ischemia, hypertension, diabetes, and hyperthyroidism, etc. was excluded. The clinical diagnostic pathway was limited to describing the structural and functional abnormalities, such as dilatation, hypertrophy, restrictive cardiomyopathies, and systolic or diastolic heart failure. With the progression of diagnostic techniques, especially of high-resolution imaging and molecular precision medicine, the previous definition and pathway cannot satisfy clinical demands. Accordingly, large medical centers with sufficient equipment should adopt a new clinical diagnostic pathway including high-resolution imaging and genetic analysis in the new era, which would supply more precise information of cardiac images and particular genetic abnormalities. This new pathway will greatly help the radiomics analysis, gene therapy, the development of targeted drugs, and genetic counseling for patients with cardiomyopathies.
    • FullText(HTML)
  • loading
    • References(23)
  • [1] Elliott P, Anderson R, Arbustini E, et al.Classification of the cardiomyopathies:a position statement from the european society of cardiology working group on myocardial and pericardial diseases[J].Eur Heart J, 2008, 29:270-276.
    [2] Arbustini E, Narula N, Tavazzi L, et al.The MOGE(S) classification of cardiomyopathy for clinicians[J].J Am Coll Cardiol, 2014, 64:304-318.
    [3] Marchesini M, Uguccioni L, Parisi R, et al.The role of cardiac magnetic resonance imaging in hypertrophic cardiomyopathy[J].Rev Cardiovasc Med, 2016, 17:57-64.
    [4] Kwon DH, Setser RM, Popović ZB, et al.Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy:a delayed contrast enhanced MRI study[J].Int J Cardiovasc Imaging, 2008, 24:617-625.
    [5] Hinojar R, Varma N, Child N, et al.T1 mapping in discrimination of hypertrophic phenotypes:hypertensive heart disease and hypertrophic cardiomyopathy:findings from the international T1 multicenter cardiovascular magnetic resonance study[J].Circ Cardiovasc Imaging, 2015, 8:pii:e003285.
    [6] Sado DM, White SK, Piechnik SK, et al.Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping[J].Circ Cardiovasc Imaging, 2013, 6:392-398.
    [7] Moon JC, Sachdev B, Elkington AG, et al.Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease.Evidence for a disease specific abnormality of the myocardial interstitium[J].Eur Heart J, 2003, 24:2151-2155.
    [8] Maceira AM, Joshi J, Prasad SK, et al.Cardiovascular magnetic resonance in cardiac amyloidosis[J].Circulation, 2005, 111:186-193.
    [9] Ellims AH, Iles LM, Ling LH, et al.A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging:linking genotype with fibrotic phenotype[J].Eur Heart J Cardiovasc Imaging, 2014, 15:1108-1116.
    [10] Gillies RJ, Kinahan PE, Hricak H.Radiomics:images are more than pictures, they are data[J].Radiology, 2016, 278:563-577.
    [11] Sengupta PP, Huang YM, Bansal M, et al.Cognitive machine-learning algorithm for cardiac imaging:A pilot study for differentiating constrictive pericarditis from restrictive cardiomyopathy[J].Circ Cardiovasc Imaging, 2016, 9:pii:e004330.
    [12] Baessler B, Luecke C, Lurz J.Cardiac MRI texture analysis of T1 and T2 maps in patients with infarctlike acute myocarditis[J].Radiology, 2018, 289:357-365.
    [13] Teekakirikul P, Kelly MA, Rehm HL, et al.Inherited cardiomyopathies:molecular genetics and clinical genetic testing in the postgenomic era[J].J Mol Diagn, 2013, 15:158-170.
    [14] Worman HJ, Bonne G."Laminopathies":A wide spectrum of human diseases[J].Exper Cell Res, 2007, 313:2121-2133.
    [15] Berne P, Brugada J.Brugada syndrome 2012[J].Circ J, 2012, 76:1563-1571.
    [16] Millat G, Chanavat V, Rousson R.Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies[J].Clin Chim Acta, 2014, 433:266-271.
    [17] Loman NJ, Misra RV, Dallman TJ, et al.Performance comparison of benchtop high throughput sequencing platforms[J].Nat Biotechnol, 2012, 30:434-439.
    [18] Zhao Y, Feng Y, Zhang YM, et al.Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy[J].Int J Mol Med, 2015, 36:1479-1486.
    [19] Bottillo I, D'Angelantonio D, Caputo V, et al.Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy[J].Gene, 2016, 577:227-235.
    [20] Lu C, Wu W, Liu F, et al.Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequenc-ing technologies[J].J Transl Med, 2018, 16:241.
    [21] Wu W, Lu CX, Wang YN, et al.Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-genera-tion sequencing[J].J Am Heart Assoc, 2015, 4:e001879
    [22] Ruan YP, Lu CX, Zhao XY, et al.Restrictive Card-iomyopathy Resulting from a Troponin I Type 3 Mutation in a Chinese Family[J].Chin Med Sci J, 2016, 31:1-7.
    [23] 徐昊鹏, 朱翀, 弓孟春, 等.中国罕见病研究的现状与未来[J].协和医学杂志, 2018, 9:5-9.
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (556) PDF downloads(189) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return